Criptococosis cerebral, voriconazol, niveles plasmáticos y síndrome de reconstitución inmune. Reporte de un caso
Palabras clave:
Acquired Immunodeficiency Syndrome, Drug monitoring, Immune Reconstitution Inflammatory Syndrome, Meningitis Cryptococcal, VoriconazoleResumen
We report a 45 years old male with AIDS who had a Cryptococcus neoformans central nervous system infection. He was treated with amphotericin B deoxycolate subsequently changed to voriconazole due to systemic toxicity of the former. Plasma voriconazole trough levels were insufficient with a standard dose (0.7 µg/mL); therefore, the dose was increased thereafter to reach appropriate levels (4.5 µg/mL). Anti-retroviral therapy was started five weeks after voriconazole initiation with non-interacting drugs and he was discharged after a favorable evolution. He was re-admitted three months later due to seizures; a brain magnetic resonance showed new sub-cortical nodules. After excluding alternative causes and demonstrating fungal eradication, an immune reconstitution inflammatory syndrome (IRIS) event was suspected and treated with a short course of steroids. His evolution was satisfactory.Descargas
Publicado
2018-11-12
Cómo citar
Téllez R, M., Salgueiro C, C., Leiva Hernández, M., & Fica, A. (2018). Criptococosis cerebral, voriconazol, niveles plasmáticos y síndrome de reconstitución inmune. Reporte de un caso. Revista Médica De Chile, 146(12). Recuperado a partir de https://revistamedicadechile.cl/index.php/rmedica/article/view/6929
Número
Sección
Reporte de Caso Clínico